1.

The laboratory’s role in healthcare has never been more important

During his keynote address,  William Morice II, M.D., Ph.D., president and CEO at Mayo Clinic Laboratories, emphasized that diagnostics generate most of the data within the medical record and serve as the foundation for clinical decision-making. As healthcare becomes increasingly complex, the value of laboratory medicine will continue to grow. Clinicians will rely more heavily on laboratory professionals to help interpret data, guide testing decisions, and translate results into actionable insights for patient care.

Dr. Morice also pointed to the rapid growth of precision medicine, genomics, proteomics, and other personalized care approaches as key drivers of laboratory innovation. These advances depend on increasingly sophisticated diagnostic testing, positioning laboratories at the center of healthcare innovation.

Erin Hoffman, division director of Sales and Service at Mayo Clinic Laboratories, shared data during her presentation that challenged the historical perception of the laboratory as simply a support service or cost center. Laboratories not only support but also drive patient care, organizational growth, and financial performance. This is especially true of organizations with outreach programs. You can learn more about this data in a Mayo Clinic Laboratories white paper.

Hoffman’s insights were further reinforced when leaders from Torrance Memorial Medical Center and United Health Services shared how they identified opportunities to better support their broader organizations by growing their laboratories’ outpatient footprints.

2.

The future belongs to laboratories that embrace change and innovation

A recurring message throughout the conference was that change is inevitable, but laboratories can choose whether to react to it or lead it. During her portion of the keynote address, Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, emphasized that curiosity, creativity, and adaptability are becoming essential leadership skills in today's rapidly evolving healthcare environment.

That theme was echoed by the leaders from Torrance Memorial and United Health Services Hospitals. Mary Kielma, administrative director for the Department of Pathology and Laboratory Medicine at United Health Services, told attendees, “You can’t stop the wind, but you can adjust your sails. It’s all about adaptability. If we accept the change, we can move ahead.”

The two organizations shared several ways they creatively solved problems and took advantage of emerging technologies and opportunities. Examples ranged from expanding in-house testing capabilities and improving connectivity across physician networks to investing in digital pathology and exploring innovative solutions, including drones for specimen transport.

Williamson also emphasized that a clear strategy is critical for navigating change and capitalizing on new opportunities.

"The biggest challenge today is, it's hard to vet what you're going to focus on," Williamson told the audience.

With countless competing priorities vying for attention, leaders need a framework for identifying which ideas are worth pursuing and a well-defined strategy can serve as a guide for decision-making. By staying focused on organizational goals, laboratory leaders can embrace innovation while maintaining clarity on their most important priorities.

3.

Technology will transform healthcare, but people remain essential

Christopher Garcia, M.D., chief digital innovation officer at Mayo Clinic Laboratories, explored how artificial intelligence and automation are creating new opportunities for laboratories. He highlighted a range of potential applications, including microvolume testing, advanced genetic testing, operational automation, forecasting, supply chain management, revenue cycle optimization, and ambient listening technologies.

While optimistic about AI's potential, Dr. Garcia emphasized that technology is not a solution for every challenge. Successful AI initiatives, he said, begin with a clearly defined problem and require strong ownership, governance, metrics, and strategy to ensure they deliver meaningful value.

Another key theme of his presentation was that AI should help laboratory professionals, not replace them. Human oversight remains essential to ensure patient safety, maintain trust, and protect the credibility of the laboratory. Rather than viewing AI as a workforce replacement tool, Dr. Garcia encouraged participants to invest in their people and empower them to work alongside emerging technologies.

The importance of the human element in healthcare was further reinforced by Victor Montori, M.D., the Robert H. and Susan M. Rewoldt Professor of Medicine at Mayo Clinic, endocrinologist, health services researcher, and care activist. He advocated for a more patient-centered approach to healthcare that emphasizes listening, partnership, and understanding each patient's unique needs. Rather than replacing human interaction, Dr. Montori suggested AI's greatest potential is helping healthcare professionals care for patients more effectively.

Together, the presentations underscored that even as technology transforms healthcare, people remain at the heart of medicine.

4.

Laboratories need a stronger voice to address growing challenges

While speakers highlighted many opportunities for laboratories, they also acknowledged several persistent challenges, including workforce shortages, reimbursement pressures, and an evolving regulatory environment.

During her presentation, Susan Van Meter, president of the American Clinical Laboratory Association, the national trade association that represents leading clinical laboratories, discussed key policy issues affecting the industry. This included pending reductions to Medicare payment to the Clinical Laboratory Fee Schedule rooted in the Protecting Access to Medicare Act (PAMA) that will take place on Jan. 1 without Congressional intervention. The field has rallied around the RESULTS Act, which would address the flaw of PAMA and mitigate future reductions. Van Meter encouraged conference attendees to visit the Stop Lab Cuts website to learn more. She also addressed prior authorization challenges; a recent, promising Centers for Medicare & Medicaid Services Request for Information on meaningful lab-specific reforms; and the latest in the regulation of laboratory-developed tests. She noted the collective role we all share in continually educating policymakers on the laboratory's role in patient care.

That need extends beyond policymakers. Throughout the conference, presenters observed that many healthcare executives do not fully understand the laboratory's contributions to patient care and operational performance. As a result, laboratories must actively communicate their value to both external stakeholders and leaders within their own organizations. The message was clear: advocacy and education are essential to ensuring laboratories can continue investing in innovation, expanding access to testing, and advancing patient care.